RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 Data from New Oral Anticoagulants Provide Clues for Future Drug Development
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 13
SP 4
OP 5
DO 10.1177/155989771313001
UL http://mdc.sagepub.com/content/13/13/4.abstract
AB The new oral anticoagulants have delivered promising results in terms of efficacy and safety. However, the data from the many clinical trials that have evaluated the new agents has provided physicians with a wealth of information for future drug development. This article presents five lessons learned from the recent clinical trials that evaluated the novel oral anticoagulant agents, including dabigatran, rivaroxaban, and apixaban.